MRKR
Marker Therapeutics Inc
NASDAQ: MRKR · HEALTHCARE · BIOTECHNOLOGY
$1.46
+0.69% today
Updated 2026-04-30
Market cap
$24.18M
P/E ratio
—
P/S ratio
6.82x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
Marker Therapeutics Inc (MRKR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $183064.00 | $205994.00 | $213194.00 | $466785.00 | $1.24M | $3.51M | $3.31M | $6.59M | $3.55M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | +12.5% | +3.5% | +118.9% | +166.0% | +183.0% | -5.8% | +99.1% | -46.2% |
| Cost of revenue | $6371.00 | $5970.00 | $7482.00 | $3741.00 | — | — | — | $-264000.00 | $0.00 | $0.00 | $0.00 | $5.25M | $124.00M | $12.76M | $18.88M | $3.16M | $11.97M | $10.42M | $13.47M | — |
| Gross profit | — | — | — | — | — | — | — | $264000.00 | $0.00 | $0.00 | $0.00 | $-5.07M | $-123.79M | $-12.55M | $-18.41M | $-1.92M | $-8.45M | $-7.11M | $-6.88M | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | -2768.4% | -60095.0% | -5887.4% | -3944.9% | -154.7% | -240.6% | -214.6% | -104.3% | 0.0% |
| R&D | $173172.00 | $425569.00 | $182343.00 | $93041.00 | $290048.00 | $203725.00 | $1.06M | $661634.00 | $189000.00 | $1.71M | $3.80M | $5.25M | $124.00M | $12.76M | $18.88M | $27.79M | $11.97M | $10.42M | $13.47M | $11.80T |
| SG&A | $708707.00 | $2.08M | $1.31M | $4.10M | $3.65M | $2.43M | $4.42M | $2.00M | $3.18M | $4.45M | $4.69M | $6.41M | $24.38M | $9.98M | $10.47M | $12.93M | $11.34M | $7.48M | $4.24M | $4.18T |
| Operating income | $-888000.00 | $-2.51M | $-1.50M | $-4.19M | $-3.94M | $-2.64M | $-6.22M | $-2.66M | $-3.37M | $-6.16M | $-8.49M | $-11.48M | $-148.17M | $-22.53M | $-28.89M | $-39.48M | $-19.79M | $-14.58M | $-11.12M | $-12.44M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | -6271.0% | -71930.3% | -10567.3% | -6188.3% | -3179.3% | -563.3% | -440.4% | -168.7% | -350.7% |
| EBITDA | $-851000.00 | $-2.50M | $-1.41M | $-3.27M | $-3.85M | $-1.35M | $-5.58M | $-3.78M | $-30.31M | $-34.06M | $6.04M | $-11.30M | $-147.97M | $-22.42M | $-27.63M | $-38.72M | $-17.00M | $-11.79M | $-11.12M | $-12.44M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | -6171.1% | -71830.2% | -10518.0% | -5919.2% | -3118.0% | -483.9% | -356.1% | -168.7% | -350.7% |
| EBIT | $-857371.00 | $-2.51M | $-1.42M | $-3.27M | $-3.94M | $-2.64M | $-6.69M | $-3.31M | $-3.37M | $-6.16M | $-2.46M | $-22.78M | $-296.14M | $-22.53M | $-28.71M | $-41.88M | $-19.79M | $-14.58M | $-11.12M | — |
| Interest expense | $446598.00 | $1.38M | $778179.00 | $1.19M | $1.24M | $679332.00 | $745074.00 | $1.76M | $575543.00 | $10925.00 | $0.00 | $0.00 | $0.00 | $0.00 | $148742.00 | $5700.00 | $15089.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.30M | $-3.89M | $-2.20M | $-4.46M | $-5.09M | $-2.03M | $-5.86M | $-5.53M | $-30.88M | $-34.07M | $-2.46M | $-10.98M | $-147.96M | $-21.43M | $-28.71M | $-41.88M | $-29.93M | $-8.24M | $-10.73M | $-12.16M |
| Net income growth (YoY) | — | -198.4% | +43.6% | -103.2% | -14.1% | +60.1% | -188.7% | +5.5% | -458.2% | -10.3% | +92.8% | -347.3% | -1247.3% | +85.5% | -34.0% | -45.9% | +28.5% | +72.5% | -30.3% | -13.3% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | -5999.0% | -71826.4% | -10050.9% | -6149.7% | -3372.7% | -851.9% | -248.8% | -162.8% | -343.0% |